Several in part contradictory studies have shown that ERK1/2 can trigger maladaptive cardiac hypertrophy, but also physiological hypertrophy23,44 or confer no impact on cardiac hypertrophy1,10–13,44–50. Here, MAPK3 is linked to cardiac hypertrophy.